•
Mar 31, 2020

Summit Therapeutics Q1 2020 Earnings Report

Total Revenue
$315K
Previous year: $324K
-2.8%
EPS
-$0.02
Previous year: -$0.04
-50.0%
Gross Profit
$386K
Previous year: $858K
-55.0%
Cash and Equivalents
$54.9M
Previous year: $35.2M
+55.9%
Free Cash Flow
-$4.99M
Previous year: -$35.3M
-85.9%

Summit Therapeutics

Summit Therapeutics